Marshall Wace
PMVP icon

Marshall Wace’s PMV Pharmaceuticals PMVP Stock Holding History

Marshall Wace’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$369K Sell
220,760
-100,850
-31% -$131K ﹤0.01% 2636
2026
Q2 		$431K Sell
321,610
-112,483
-26% -$144K ﹤0.01% 2583
2026
Q1 		$538K Sell
434,093
-30,993
-7% -$39.4K ﹤0.01% 2411
2025
Q4 		$581K Sell
465,086
-147,540
-24% -$198K ﹤0.01% 2181
2025
Q3 		$858K Buy
+612,626
New +$848K ﹤0.01% 2009
2025
Q1 		– Sell
-11,014
Closed -$16.6K – 2994
2024
Q4 		$16.6K Sell
11,014
-50,677
-82% -$80.3K ﹤0.01% 2515
2024
Q3 		$91.9K Buy
61,691
+48,791
+378% +$75.4K ﹤0.01% 2383
2024
Q2 		$20.9K Sell
12,900
-118,945
-90% -$215K ﹤0.01% 2470
2024
Q1 		$224K Buy
+131,845
New +$246K ﹤0.01% 2202
2023
Q4 		– Sell
-58,062
Closed -$357K – 2517
2023
Q3 		$357K Buy
+58,062
New +$399K ﹤0.01% 1822
2023
Q2 		– Sell
-33,225
Closed -$158K – 2876
2023
Q1 		$158K Sell
33,225
-32,982
-50% -$232K ﹤0.01% 2438
2022
Q4 		$576K Buy
66,207
+21,000
+46% +$224K ﹤0.01% 2318
2022
Q3 		$538K Buy
+45,207
New +$653K ﹤0.01% 2688
2021
Q4 		– Sell
-12,716
Closed -$379K – 4197
2021
Q3 		$379K Buy
+12,716
New +$406K ﹤0.01% 2540
2021
Q1 		– Sell
-16,193
Closed -$996K – 2778
2020
Q4 		$996K Buy
+16,193
New +$635K 0.01% 1215

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BIT Capital
BIT Capital Berlin, Germany $2.89B AUM 111.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aldebaran Capital
Aldebaran Capital Carmel, Indiana $139M AUM 35.88% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Marshall Wace's PMVP Position: Q3 2026 in Review

Marshall Wace reduced its PMV Pharmaceuticals (PMVP) stake by 31% in Q3 2026, selling an estimated $131K and leaving 220,760 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2636.

Marshall Wace first reported a position in PMVP in Q4 2020 and has held it in 15 quarters since. The position peaked at $996K in Q4 2020. 36 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Marshall Wace held 220,760 shares of PMV Pharmaceuticals worth $369K as of Q3 2026.
  • Marshall Wace sold 100,850 PMV Pharmaceuticals shares in Q3 2026, an estimated $131K.
  • PMV Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q3 2026, its #2636 holding.
  • Marshall Wace first reported a position in PMV Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • Marshall Wace's PMV Pharmaceuticals position peaked at $996K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.